AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24731111 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual brief motivational intervention (iBMI)
Number of subjects: 278
Study 24731111 — intervention group
Group type: EXPERIMENTAL
Intervention: Group brief motivational intervention (gBMI)
Number of subjects: 278
Study 22594116 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrounding acupuncture plus electric acupuncture (Group A)
Number of subjects: 500
Study 22594116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton‐sheet moxibustion (Group B)
Number of subjects: 500
Study 22594116 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncturing with red‐hot needles (Group C)
Number of subjects: 500
Study 22594116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapping plus cupping (Group D)
Number of subjects: 500
Study 22594116 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (Group E)
Number of subjects: 500
Study 20171359 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 40
Study 20171359 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40
Study 20171359 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 40
Study 20171359 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 40
Study 20171359 — intervention group
Group type: EXPERIMENTAL
Intervention: Both articaine and lidocaine
Number of subjects: 40
Study 18570129 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor (no specific intervention mentioned)
Number of subjects: 301
Study 15780173 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel plus prednisone
Number of subjects: 0
Study 15780173 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel plus estramustine
Number of subjects: 0
Study 15780173 — intervention group
Group type: COMPARATOR
Intervention: mitoxantrone plus prednisone
Number of subjects: 0
Study 14622078 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 347
Study 14622078 — intervention group
Group type: COMPARATOR
Intervention: Nefazodone
Number of subjects: 347
Study 14622078 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (Nefazodone + CBASP)
Number of subjects: 347
Study 10777184 — intervention group
Group type: COMPARATOR
Intervention: EHC (extra-hepatic cholestasis)
Number of subjects: 80
Study 10777184 — intervention group
Group type: COMPARATOR
Intervention: IHC (intrahepatic cholestasis)
Number of subjects: 80
Study 8823020 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐0 polydioxanone
Number of subjects: 20
Study 8823020 — intervention group
Group type: COMPARATOR
Intervention: 6‐0 polyglactin 910
Number of subjects: 20
Study 1527133 — intervention group
Group type: EXPERIMENTAL
Intervention: A-V Impulse System
Number of subjects: 82
Study 1527133 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 3736141 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly feedback reports of compliance with preventive care protocols
Number of subjects: 135
Study 3736141 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific reminders given at the time of patient visits
Number of subjects: 135
Study 3736141 — intervention group
Group type: COMPARATOR
Intervention: Reminders alone
Number of subjects: 135
Study 3736141 — intervention group
Group type: COMPARATOR
Intervention: Neither feedback nor reminders
Number of subjects: 135
Study 31532824 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous bone ring transplant (BR)
Number of subjects: 34
Study 31532824 — intervention group
Group type: COMPARATOR
Intervention: Autologous growth factor-enriched bone graft matrix (AFG)
Number of subjects: 34
Study 29570467 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside respiratory muscle training (twice a day for 3 weeks) including breath stacking exercise, inspiratory muscle training, and expiratory muscle training.
Number of subjects: 40
Study 29570467 — intervention group
Group type: COMPARATOR
Intervention: Conventional stroke rehabilitation program (control group).
Number of subjects: 40
Study 26699603 — intervention group
Group type: EXPERIMENTAL
Intervention: BALANCE Program (prescribed diet, nutritional education strategy, intensive follow-up)
Number of subjects: 2468
Study 26699603 — intervention group
Group type: COMPARATOR
Intervention: Generic advice on low-fat, low-energy, low-sodium, and low-cholesterol diet
Number of subjects: 2468
Study 23975250 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 222
Study 23975250 — intervention group
Group type: COMPARATOR
Intervention: Internal fixation with two parallel screws
Number of subjects: 222
Study 22709769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Work, Weight, and Wellness trial)
Number of subjects: 4236
Study 22709769 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4236
Study 22709769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 4236
Study 21147707 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey-predominant formula containing LCPUFAs and oligosaccharides (FOS/GOS)
Number of subjects: 144
Study 21147707 — intervention group
Group type: COMPARATOR
Intervention: Control casein-predominant formula
Number of subjects: 144
Study 21147707 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 144
Study 18204158 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 18204158 — intervention group
Group type: EXPERIMENTAL
Intervention: New strategies to control inflammation in COPD
Number of subjects: 0
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: Bell side of the acoustic stethoscope
Number of subjects: 250
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragm side of the acoustic stethoscope
Number of subjects: 250
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency amplification of systolic Korotkoff sounds
Number of subjects: 250
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency amplification of systolic Korotkoff sounds
Number of subjects: 250
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency amplification of diastolic Korotkoff sounds
Number of subjects: 250
Study 15716689 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency amplification of diastolic Korotkoff sounds
Number of subjects: 250
Study 12222753 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of metformin with 500 mg of cephalexin
Number of subjects: 12
Study 12222753 — intervention group
Group type: COMPARATOR
Intervention: 500 mg of metformin with placebo
Number of subjects: 12
Study 10559616 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg modified release formulation once daily)
Number of subjects: 355
Study 10559616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 8551449 — intervention group
Group type: EXPERIMENTAL
Intervention: Type A IOLs (convex-plano)
Number of subjects: 0
Study 8551449 — intervention group
Group type: EXPERIMENTAL
Intervention: Type B IOLs (biconvex, anterior more curved)
Number of subjects: 0
Study 8551449 — intervention group
Group type: EXPERIMENTAL
Intervention: Type D IOLs (biconvex, posterior more curved)
Number of subjects: 0
Study 8551449 — intervention group
Group type: EXPERIMENTAL
Intervention: Type A, B, and C IOLs
Number of subjects: 0
Study 8551449 — intervention group
Group type: EXPERIMENTAL
Intervention: Type D IOLs
Number of subjects: 0
Study 2128029 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic (specific dosage and duration not mentioned)
Number of subjects: 0
Study 2128029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 365009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cephalothin combined with mechanical colon cleansing
Number of subjects: 0
Study 365009 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (not specified, likely oral neomycin-erythromycin base and mechanical colon cleansing)
Number of subjects: 0
Study 29886499 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative enteral nutrition enriched with eicosapentaenoic acid (EPA) (600 kcal/day for 7 days)
Number of subjects: 20
Study 29886499 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous standard nutrition (600 kcal/day for 7 days)
Number of subjects: 20
Study 28034693 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational text message daily and instructive phone calls three days a week for three months along with usual care
Number of subjects: 66
Study 28034693 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study 26227279 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal formulation (VF)
Number of subjects: 9
Study 26227279 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced glycerin vaginal formulation (RGVF)
Number of subjects: 9
Study 26227279 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoosmolal rectal-specific formulation (RF)
Number of subjects: 9
Study 26227279 — intervention group
Group type: COMPARATOR
Intervention: Simulated unprotected receptive anal intercourse (RAI)
Number of subjects: 9
Study 25005333 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D co-supplementation (50,000 U/week vitamin D + 1,000 mg/day calcium)
Number of subjects: 118
Study 22390325 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye patches (four main brands)
Number of subjects: 24
Study 20533214 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (250 mg every other day for 12 weeks)
Number of subjects: 42
Study 20533214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 17804954 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) cognitive testing
Number of subjects: 107
Study 17804954 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic Remote Evaluation of Neuropsychological Deficit tasks
Number of subjects: 107
Study 17804954 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR informant data
Number of subjects: 107
Study 15080373 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg daily) with or without indapamide (2 mg daily)
Number of subjects: 667
Study 15080373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 667
Study 15080373 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 667
Study 12190102 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS) screening examination
Number of subjects: 4956
Study 9818624 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8-10 mg/day)
Number of subjects: 549
Study 9818624 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20-40 mg/day)
Number of subjects: 549
Study 9818624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 549
Study 7650634 — intervention group
Group type: EXPERIMENTAL
Intervention: Corporate values perceived importance
Number of subjects: 0
Study 7650634 — intervention group
Group type: EXPERIMENTAL
Intervention: Corporate values related to occupational group, gender, age, and company size
Number of subjects: 0
Study 2782470 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus standard treatment
Number of subjects: 45
Study 2782470 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training plus standard treatment
Number of subjects: 45
Study 2782470 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (hospital milieu therapy, pharmacotherapy, clinical management sessions)
Number of subjects: 45
Study 7034157 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic YAG-laser treatment
Number of subjects: 135
Study 7034157 — intervention group
Group type: COMPARATOR
Intervention: Control group (active surgical approach)
Number of subjects: 135
Study 7034157 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic YAG-laser treatment vs Control group
Number of subjects: 135
Study 30864452 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger children (6-9 years)
Number of subjects: 2
Study 30864452 — intervention group
Group type: COMPARATOR
Intervention: Adolescents (10-17 years)
Number of subjects: 2
Study 28224296 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-6D utility scores
Number of subjects: 294
Study 28224296 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L utility scores
Number of subjects: 294
Study 25893652 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D high-definition (HD) display
Number of subjects: 40
Study 25893652 — intervention group
Group type: COMPARATOR
Intervention: 2D HD imaging system
Number of subjects: 40
Study 24061999 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (0.25 g tid po for 1 week)
Number of subjects: 30
Study 24061999 — intervention group
Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 30
Study 21861028 — intervention group
Group type: EXPERIMENTAL
Intervention: GT rotary instruments
Number of subjects: 60
Study 21861028 — intervention group
Group type: EXPERIMENTAL
Intervention: ProFile rotary instruments
Number of subjects: 60
Study 21861028 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments
Number of subjects: 60
Study 21861028 — intervention group
Group type: EXPERIMENTAL
Intervention: K3 rotary instruments
Number of subjects: 60
Study 21861028 — intervention group
Group type: COMPARATOR
Intervention: Hand K-files
Number of subjects: 60
Study 21861028 — intervention group
Group type: COMPARATOR
Intervention: Hero instruments
Number of subjects: 60
Study 19652953 — intervention group
Group type: EXPERIMENTAL
Intervention: High PEEP (11.0 cmH2O) with high respiratory rate
Number of subjects: 11
Study 19652953 — intervention group
Group type: EXPERIMENTAL
Intervention: High PEEP (11.0 cmH2O) with low respiratory rate
Number of subjects: 11
Study 19652953 — intervention group
Group type: COMPARATOR
Intervention: Low PEEP (5.4 cmH2O)
Number of subjects: 11
Study 18322814 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR CT genotype
Number of subjects: 1603
Study 18322814 — intervention group
Group type: COMPARATOR
Intervention: Total folate intake
Number of subjects: 1603
Study 15208845 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdiagnosis parent mentoring intervention
Number of subjects: 0
Study 15208845 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention during the 6-month trial)
Number of subjects: 0
Study 11240078 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion into the masseter muscle
Number of subjects: 10
Study 11240078 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline infusion in the contralateral masseter (control)
Number of subjects: 10
Study 9341430 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydropolymer dressing (Tielle)
Number of subjects: 199
Study 9341430 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressing (Granuflex)
Number of subjects: 199
Study 8286300 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-containing composite cement
Number of subjects: 0
Study 8286300 — intervention group
Group type: COMPARATOR
Intervention: Conventional adhesive (Concise)
Number of subjects: 0
Study 3735482 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 0.15 g per kg body weight
Number of subjects: 6
Study 3735482 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 0.30 g per kg body weight
Number of subjects: 6
Study 3735482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 11756618 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Sprotte needle
Number of subjects: 230
Study 11756618 — intervention group
Group type: COMPARATOR
Intervention: Traumatic Quincke needle
Number of subjects: 230
Study 31427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 80 mg/kg every 6 h infused over 2 h for ages 2 to 5 months
Number of subjects: 79
Study 31427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 90 mg/kg every 8 h infused over 4 h for ages 6 months to 6 years
Number of subjects: 79
Study 31427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 75 mg/kg every 4 h infused over 0.5 h for infants ages 2 to <6 months
Number of subjects: 79
Study 31427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam (TZP) 130 mg/kg every 8 h infused over 4 h for children ages >6 months to 6 years
Number of subjects: 79
Study 31427292 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events during treatment
Number of subjects: 79
Study 28725956 — intervention group
Group type: EXPERIMENTAL
Intervention: Child‐ and Family‐Focused Cognitive‐Behavioral Therapy (CFF‐CBT)
Number of subjects: 72
Study 28725956 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 72
Study 28725956 — intervention group
Group type: EXPERIMENTAL
Intervention: NSSI presence
Number of subjects: 72
Study 28725956 — intervention group
Group type: EXPERIMENTAL
Intervention: NSSI absence
Number of subjects: 72
Study 27166709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ajwain 10 % topical cream
Number of subjects: 92
Study 27166709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 25420431 — intervention group
Group type: EXPERIMENTAL
Intervention: Monsenso system including a feedback loop between patients and clinicians
Number of subjects: 0
Study 25420431 — intervention group
Group type: COMPARATOR
Intervention: Smartphone for normal communicative purposes
Number of subjects: 0
Study 22595063 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 0.6 mg/kg per day for 12 weeks
Number of subjects: 42
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of latent TB infection (LTBI)
Number of subjects: 720
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month isoniazid regimen
Number of subjects: 720
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: Residence in a congregate setting (nursing home, shelter, or jail)
Number of subjects: 720
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection drug use
Number of subjects: 720
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >or= 15 years
Number of subjects: 720
Study 19793865 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment at a health-care facility
Number of subjects: 720
Study 17277594 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine/Carbohydrate (CrCHO)
Number of subjects: 4
Study 17277594 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine/Whey Protein (CrWP)
Number of subjects: 4
Study 17277594 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 4
Study 17277594 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate only (CHO)
Number of subjects: 4
Study 16198216 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple advice and educational booklet given to non-smoking pregnant women (intervention group)
Number of subjects: 758
Study 16198216 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 758
Study 12416945 — intervention group
Group type: COMPARATOR
Intervention: Cardioselective β-blocker (single dose)
Number of subjects: 29
Study 12416945 — intervention group
Group type: COMPARATOR
Intervention: Cardioselective β-blocker (continued treatment)
Number of subjects: 29
Study 12416945 — intervention group
Group type: COMPARATOR
Intervention: Cardioselective β-blocker (single dose) in patients with COPD
Number of subjects: 29
Study 12416945 — intervention group
Group type: COMPARATOR
Intervention: Cardioselective β-blocker (continued treatment) in patients with COPD
Number of subjects: 29
Study 10220232 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 10220232 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0
Study 10220232 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0
Study 10220232 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study 10220232 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall costs for all agents except chlorthalidone
Number of subjects: 0
Study 7752269 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (40 mg daily for 2 years)
Number of subjects: 2729
Study 1973717 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant treatment (Reconstituted bovine surfactant, 120 mg/kg body weight, delivered in 5 divided doses)
Number of subjects: 18
Study 1973717 — intervention group
Group type: COMPARATOR
Intervention: Air placebo (4 ml per kilogram)
Number of subjects: 18
Study 1973717 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant treatment
Number of subjects: 18
Study 1973717 — intervention group
Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 18
Study 7191298 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg oxprenolol twice a day
Number of subjects: 11
Study 7191298 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg slow-release oxprenolol once a day
Number of subjects: 11
Study 31227466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided single-dose interscalene block (USG SDIB)
Number of subjects: 20
Study 31227466 — intervention group
Group type: COMPARATOR
Intervention: Balanced general anesthesia (BGA)
Number of subjects: 20
Study 28961662 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram monotherapy (DOCS group)
Number of subjects: 2280
Study 28961662 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram monotherapy (non-DOCS group)
Number of subjects: 2280
Study 28961662 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission from MDD (both groups)
Number of subjects: 2280
Study 26505723 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% normal saline
Number of subjects: 100
Study 26505723 — intervention group
Group type: COMPARATOR
Intervention: 0.1% polyhexanide plus 0.1% betaine
Number of subjects: 100
Study 23842022 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone (up to 9 mg/d)
Number of subjects: 34
Study 23842022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 23842022 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 34